Workplace Substance Abuse Program Sample Clauses

Workplace Substance Abuse Program. ‌ (a) Drug Control Program Including “Random” and “For Cause” Testing Drug testing under the Workplace Substance Abuse Program (WSAP) will be conducted using existing testing procedures and protocols. During the term of the contract, no employee tested randomly for drug use will be automatically terminated for a first time positive random test. This does not mean that termination is precluded. All union positions within the Company shall be WSAP Positions (b) The items listed below describe the basic terms, but not all details of the program as implemented. Current procedures and protocols will be utilized in administering the program. 1. Illegal drugs include any substance, which under the Federal Controlled Substances Act or state statute is unlawful to possess. Examples are marijuana, cocaine, heroin, quaaludes, hallucinogens, and other street drugs; and controlled prescription drugs such as amphetamines and barbiturates that have not been lawfully prescribed for the individual using or possessing them. 2. Employees who manufacture, use, possess, or traffic in illegal drugs whether on or off the job or Company premises subject themselves to disciplinary action up to and including termination, even for a first offense. An employee will not be retained on the payroll following a second offense 3. The Company encourages any employee having a drug problem to seek medical assistance promptly. Employees may elect to take advantage of counseling and rehabilitation services available through referrals by our medical department as provided by the health care plan. In cases where the employee is found to be in violation of this policy, but not terminated, the Company will strongly urge and may require that employee to obtain appropriate medical assistance. If an employee has a drug problem and voluntarily seeks the help of the Medical Department to overcome the problem, the services of the Medical Department are available to the employee. Medical may refer the employee to outside groups for special assistance when appropriate. An employee’s decision to seek medical assistance will not be used by the Company as a basis for disciplinary action, nor will it be a defense to or a mitigating factor in the imposition of appropriate disciplinary action, including termination, where facts indicating a violation of this policy are obtained independent of the employee’s consultations with the Medical Department. 4. Where there is reasonable suspicion to believe that an employe...
Sample 1Sample 2Sample 3See All (6)
AutoNDA by SimpleDocs
Workplace Substance Abuse Program. (WSAP) (a) Applies to -- This clause applies to subcontracts $25,000 or greater and which involve: (1) access to or handling of classified information or special nuclear materials; (2) high risk of danger to life, the environment, public health and safety, or national security; (3) transportation of hazardous materials to or from a DOE site, (4) employees who are required to have L or Q clearances to perform work under this Agreement, or (5) on–site construction activities. (b) WSAP Covered Work -- For purposes of this clause, “WSAP covered work” means both on-site work, and work that is not on-site but that is performed by subcontractor employees with Q or L clearances at facilities that have Limited Areas (security areas designated by DOE for the protection of classified matter). Facilities that are not DOE- owned or –leased or Company-owned or -leased but that have Limited Areas within them are known as “possessing facilities.” (c) Sub-tier contractors to Seller -- Seller shall include this requirement in its contracts with applicable lower tier subcontractors, and will require those subcontractors to include this requirement in their subcontracts, if the applicability standards listed in the “Applies to” section above are met. References to “Seller” include all lower tier subcontractors falling within the “Applies to” criteria listed in subparagraph (a) above. (d) Company approval of Seller Program (1) All work falling within the “Applies to” criteria above is subject to 10 CFR 707, “Workplace Substance Abuse Programs at DOE Sites.” This clause highlights certain provisions of 10 CFR Part 707, but Seller is directed to the entire provision to ensure compliance. The Seller shall develop and implement a workplace substance abuse program that complies with the requirements of 10 CFR Part 707. In accordance with 10 CFR 707.5(d), Seller’s WSAP requires Company approval. Seller’s proposed WSAP must be submitted to the Subcontract Administrator and approved before the start of work. (2) Seller shall also submit applicable lower-tier subcontractor WSAPs for Company approval. Seller may either include employees of some or all subcontractors in its WSAP, or include this clause in subcontracts for WSAP covered work and require subcontractors to submit WSAPs for Company approval.
Sample 1
Workplace Substance Abuse Program. (WSAP) (1) Drug testing under WSAP will be conducted using existing testing procedures and protocols. (2) During the term of the Contract, random drug testing will be performed only in Testing Designated Positions (TDP) as determined by DOE. (3) Bargaining Unit employees testing positive under this program will be allowed the opportunity for rehabilitation as outlined in the program for the first positive test. (4) The Company and the Union will negotiate during the term of the new Contract with respect to other impacts of WSAP upon the bargaining unit if such negotiations are required.
Sample 1
Workplace Substance Abuse Program. The Company is committed to maintaining an alcohol- and drug-free workplace and to establish a program in accordance with the requirements of 10CFR707, Workplace Substance Abuse Programs at DOE Sites, as amended on February 22, 2008, which includes the Mandatory Guidelines for Federal Workplace Testing Programs issued by the Department of Health and Human Services, Controlled Substances Act, and Department of Transportation regulations (DOT) . The Company shall employ individuals who refrain from the use, possession, sale, distribution, or manufacture of illegal narcotics or their synthetic equivalent, including alcohol, in order to provide safe workplaces for its project members and maintain programs promoting high standards of conduct to ensure safety and productivity . Conditions for employment of all personnel include: a . Subjection to pre-employment and random drug and alcohol testing b . Requirement to report for work and remain at work in a condition fit to perform assigned duties c . Be prohibited from possessing or carrying specimen altering paraphernalia and/or illegal drugs/paraphernalia d . Restriction from participating in illegal drug activity on or off the job, including the use of synthetic drugs e . Restriction of consuming alcoholic beverages during the workday or at any time that will impair performance on the job f . Violation of this prohibition or requirement may result in unpaid suspension, termination of employment, or mandatory enrollment in a Company approved substance abuse rehabilitation program .
Sample 1

Related to Workplace Substance Abuse Program

  • Substance Abuse Program The SFMTA General Manager or designee will manage all aspects of the FTA-mandated Substance Abuse Program. He/she shall have appointing and removal authority over all personnel working for the Substance Abuse Program personnel, and shall be responsible for the supervision of the SAP.

  • Substance Abuse The dangers and costs that alcohol and other chemical abuses can create in the electrical contracting industry in terms of safety and productivity are significant. The parties to this Agreement resolve to combat chemical abuse in any form and agree that, to be effective, programs to eliminate substance abuse and impairment should contain a strong rehabilitation component. The local parties recognize that the implementation of a drug and alcohol policy and program must be subject to all applicable federal, state, and local laws and regulations. Such policies and programs must also be administered in accordance with accepted scientific principles, and must incorporate procedural safeguards to ensure fairness in application and protection of legitimate interests of privacy and confidentiality. To provide a drug-free workforce for the Electrical Construction Industry, each IBEW local union and NECA chapter shall implement an area-wide Substance Abuse Testing Policy. The policy shall include minimum standards as required by the IBEW and NECA. Should any of the required minimum standards fail to comply with federal, state, and/or local laws and regulations, they shall be modified by the local union and chapter to meet the requirements of those laws and regulations.

  • SUBSTANCE ABUSE POLICY See applicable administrative policy.

  • Substance Abuse Testing The Parties agree that it is in the best interest of all concerned to promote a safe working environment. The Union has no objection to pre-employment substance abuse testing when required by the Employer and further, the Union has no objection to voluntary substance abuse testing to qualify for employment on projects when required by a project owner. The cost and scheduling of such testing shall be paid for and arranged by the Employer. The Union agrees to reimburse the Employer for any failed pre-access Alcohol and Drug test costs.

  • Workplace Safety The parties to this Agreement commit themselves to achieving the highest possible standards of occupational health and safety including adherence to the consultative and issue resolution processes included herein. Participation in and support for building and construction industry initiatives to improve construction industry standards in occupational health and safety will form an important part of this commitment. Observance of relevant Acts, Regulations, and Codes of Practice are the minimum level acceptable to enable employers and employees to meet their responsibilities and to work safely and follow health and safety rules in their workplace. On all sites there will be developed a site safety plan and job specific ‘job safety analysis’ to identify and manage the risks associated with work on each particular site. Such safety plan will include suitable procedures for personnel/material access, and site evacuation procedures. The Incolink Safety Handbook ‘SAFE’ (as amended) is endorsed by this Agreement as a proper guide and reference source for safety management and control of risks. 1) The parties agree that the WorkSafe Australia Guidance Notes on Material Safety Data Sheets shall be observed at all times. 2) Hearing tests: Audiometric tests should be conducted within two months of a person commencing employment, and thereafter at intervals of two years.

  • Substance Abuse Treatment Information Substance abuse treatment information shall be maintained in compliance with 42 C.F.R. Part 2 if the Party or subcontractor(s) are Part 2 covered programs, or if substance abuse treatment information is received from a Part 2 covered program by the Party or subcontractor(s).

  • Quality Assurance Program An employee shall be entitled to leave of absence without loss of earnings from her or his regularly scheduled working hours for the purpose of writing examinations required by the College of Nurses of Ontario arising out of the Quality Assurance Program.

  • HIV/AIDS Model Workplace Guidelines Grantee will: a. implement the System Agency’s policies based on the Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), AIDS Model Workplace Guidelines for Businesses at xxxx://xxx.xxxx.xxxxx.xx.xx/hivstd/policy/policies.shtm, State Agencies and State Grantees Policy No. 090.021. b. educate employees and clients concerning HIV and its related conditions, including AIDS, in accordance with the Texas. Health & Safety Code §§ 85.112-114.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.

  • DRUGS & ALCOHOL Any incidents concerning drugs and/or alcohol shall be dealt with in accordance with the policy of the Building Industry Group Drug and Alcohol Safety and Rehabilitation Program as detailed in Appendix D of this Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!